Table 2 Lung cancer mortality ASR-E ratio (Q5 vs. Q1) and 95% confidence interval by sex and year. Spain, 2011–2017. (ASR-E: Age-standardized rates considering the 2013 European standard population)
Sex | Year | ASR-E mortality ratio Q5 vs. Q1 (CI 95%) |
|---|---|---|
Men | 2011 | 1.21 (1.15–1.27) |
2012 | 1.17 (1.12–1.23) | |
2013 | 1.17 (1.11–1.23) | |
2014 | 1.08 (1.03–1.13) | |
2015 | 1.11 (1.06–1.17) | |
2016 | 1.11 (1.05–1.16) | |
2017 | 1.15 (1.10–1.21) | |
Women | 2011 | 0.62 (0.56–0.69) |
2012 | 0.63 (0.57–0.70) | |
2013 | 0.58 (0.52–0.64) | |
2014 | 0.60 (0.54–0.66) | |
2015 | 0.58 (0.52–0.64) | |
2016 | 0.56 (0.51–0.62) | |
2017 | 0.62 (0.57–0.69) |